Literature DB >> 15653374

IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor.

Filip R Rega1, Bart M Vanaudenaerde, Wim A Wuyts, Nicole C Jannis, Geert M Verleden, Toni E Lerut, Dirk E M Van Raemdonck.   

Abstract

BACKGROUND: Viability testing of the pulmonary graft retrieved from the non-heart-beating donor (NHBD) is mandatory for successful outcome after lung transplantation. Functional assessment by ex vivo reperfusion, however, remains a cumbersome procedure. In this study, therefore, we wanted to investigate the possible value of the proinflammatory cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) measured in bronchial lavage fluid (BLF) in predicting functional outcome of the pulmonary graft after reperfusion.
METHODS: Domestic pigs (29.9 +/- 0.56 kg) were sacrificed and divided in 5 groups (n = 5/group). In the non-ischemic group (NHBD-0), the heart-lung block was explanted immediately. In the other groups the animals were left untouched with increasing time intervals (1 hour = NHBD-1; 2 hours = NHBD-2; 3 hours = NHBD-3). Thereafter both lungs were cooled topically via chest drains up to a total ischemic interval of 4 hours. Finally, in the heart-beating donor group lungs were flushed and stored for 4 hours (4 degrees C) [HBD]. BLF samples were taken from the right lung in all groups after explantation for measurement of IL-1beta and TNF-alpha and the left lung was prepared for evaluation in an isolated reperfusion circuit. Haemodynamic, aerodynamic and oxygenation parameters were measured. Wet-to-dry weight ratio (W/D) was calculated after reperfusion.
RESULTS: Graft function deteriorated with increasing time intervals after death. A strong correlation was found between the increase of IL-1beta concentration measured in BLF and the increase in pulmonary vascular resistance (r = 0.80), mean airway pressure (r = 0.74) and wet-to dry weight ratio (r = 0.78); (p < 0.0001, for all parameters). No significant differences in TNF-alpha levels in BLF were observed amongst groups (p = 0.933).
CONCLUSIONS: IL-1beta in BLF prior to reperfusion correlated well with graft function and may therefore be a useful, non-invasive marker that can predict the viability of the pulmonary graft from the NHBD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653374     DOI: 10.1016/j.healun.2003.10.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

Review 1.  Non-heart-beating donation in Spain.

Authors:  David Gomez-de-Antonio; Andres Varela
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

Review 2.  Clinical relevance of lung-restricted antibodies in lung transplantation.

Authors:  Mahzad Akbarpour; Qiang Wu; Xianpeng Liu; Haiying Sun; Emilia Lecuona; Rade Tomic; Sangeeta Bhorade; Thalachallour Mohanakumar; Ankit Bharat
Journal:  Hum Immunol       Date:  2019-05-08       Impact factor: 2.850

Review 3.  Donors after cardiocirculatory death and lung transplantation.

Authors:  Ilhan Inci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

4.  Crosstalk between nonclassical monocytes and alveolar macrophages mediates transplant ischemia-reperfusion injury through classical monocyte recruitment.

Authors:  Chitaru Kurihara; Emilia Lecuona; Qiang Wu; Wenbin Yang; Félix L Núñez-Santana; Mahzad Akbarpour; Xianpeng Liu; Ziyou Ren; Wenjun Li; Melissa Querrey; Sowmya Ravi; Megan L Anderson; Emily Cerier; Haiying Sun; Megan E Kelly; Hiam Abdala-Valencia; Ali Shilatifard; Thalachallour Mohanakumar; G R Scott Budinger; Daniel Kreisel; Ankit Bharat
Journal:  JCI Insight       Date:  2021-03-22

5.  Ex Vivo Lung Perfusion in Lung Transplantatio.

Authors:  Seokjin Haam
Journal:  J Chest Surg       Date:  2022-08-05

6.  Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.

Authors:  Ilhan Inci; Stephan Arni; Ilker Iskender; Necati Citak; Josep Monné Rodriguez; Miriam Weisskopf; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Marie Pierre Krafft; Donat R Spahn
Journal:  Cells       Date:  2020-11-18       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.